tiprankstipranks
Novonesis (GB:0Q4U)
LSE:0Q4U
UK Market
Want to see GB:0Q4U full AI Analyst Report?

Novonesis (0Q4U) Share Forecast & Price Target

14 Followers
See the Price Targets and Ratings of:

0Q4U Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Novonesis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0Q4U Stock 12 Month Forecast

Average Price Target

kr453.57
▲(19.02% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Novonesis in the last 3 months. The average price target is kr453.57 with a high forecast of kr500.00 and a low forecast of kr410.00. The average price target represents a 19.02% change from the last price of kr381.10.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"367":"kr367","434":"kr434","501":"kr501","400.5":"kr400.5","467.5":"kr467.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":500,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">kr500.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":453.57142857142856,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">kr453.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":410,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">kr410.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[367,400.5,434,467.5,501],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,390.788,399.18892307692306,407.58984615384617,415.9907692307692,424.3916923076923,432.7926153846154,441.1935384615385,449.59446153846153,457.99538461538464,466.3963076923077,474.7972307692308,483.19815384615384,491.59907692307695,{"y":500,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,390.788,395.6174945054945,400.446989010989,405.2764835164835,410.10597802197805,414.93547252747254,419.76496703296704,424.59446153846153,429.423956043956,434.2534505494505,439.08294505494507,443.91243956043957,448.74193406593406,{"y":453.57142857142856,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,390.788,392.26584615384616,393.7436923076923,395.22153846153844,396.69938461538464,398.1772307692308,399.65507692307693,401.1329230769231,402.6107692307692,404.08861538461537,405.56646153846157,407.0443076923077,408.52215384615386,{"y":410,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":421.276,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":458.419,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":445.087,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":410.947,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":400.525,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.225,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":384,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":396.373,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.86,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":378.558,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":368.397,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":388.212,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":390.788,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Targetkr500.00Average Price Targetkr453.57Lowest Price Targetkr410.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on GB:0Q4U
Kepler Capital
Kepler Capital
kr460
Buy
20.70%
Upside
Reiterated
05/18/26
Novonesis (0Q4U) Gets a Buy from Kepler Capital
Citi
kr415kr440
Buy
15.46%
Upside
Reiterated
05/08/26
Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi
Barclays Analyst forecast on GB:0Q4U
Barclays
Barclays
kr460kr470
Buy
23.33%
Upside
Reiterated
05/05/26
Barclays Remains a Buy on Novonesis (0Q4U)
Jefferies
kr450
Buy
18.08%
Upside
Reiterated
04/23/26
Jefferies Remains a Buy on Novonesis (0Q4U)
J.P. Morgan Analyst forecast on GB:0Q4U
J.P. Morgan
J.P. Morgan
kr540kr500
Buy
31.20%
Upside
Reiterated
04/09/26
Novonesis price target lowered to DKK 500 from DKK 540 at JPMorganNovonesis price target lowered to DKK 500 from DKK 540 at JPMorgan
Rothschild & Co Redburn Analyst forecast on GB:0Q4U
Rothschild & Co Redburn
Rothschild & Co Redburn
kr445
Buy
16.77%
Upside
Upgraded
03/27/26
Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn
Berenberg Bank Analyst forecast on GB:0Q4U
Berenberg Bank
Berenberg Bank
kr478kr410
Buy
7.58%
Upside
Reiterated
03/11/26
Novonesis price target lowered to DKK 410 from DKK 478 at BerenbergNovonesis price target lowered to DKK 410 from DKK 478 at Berenberg
Morgan Stanley Analyst forecast on GB:0Q4U
Morgan Stanley
Morgan Stanley
kr569kr560
Buy
46.94%
Upside
Reiterated
11/26/25
New Buy Rating for Novonesis (0Q4U), the Technology Giant
Goldman Sachs Analyst forecast on GB:0Q4U
Goldman Sachs
Goldman Sachs
kr550
Buy
44.32%
Upside
Reiterated
11/11/25
New Buy Rating for Novonesis (0Q4U), the Technology Giant
UBS
kr470kr445
Buy
16.77%
Upside
Reiterated
09/30/25
Novonesis (0Q4U): New Buy Recommendation for This Technology Giant
Deutsche Bank
kr490kr480
Buy
25.95%
Upside
Reiterated
09/24/25
Novonesis (0Q4U): New Buy Recommendation for This Technology Giant
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on GB:0Q4U
Kepler Capital
Kepler Capital
kr460
Buy
20.70%
Upside
Reiterated
05/18/26
Novonesis (0Q4U) Gets a Buy from Kepler Capital
Citi
kr415kr440
Buy
15.46%
Upside
Reiterated
05/08/26
Novonesis price target raised to DKK 440 from DKK 415 at CitiNovonesis price target raised to DKK 440 from DKK 415 at Citi
Barclays Analyst forecast on GB:0Q4U
Barclays
Barclays
kr460kr470
Buy
23.33%
Upside
Reiterated
05/05/26
Barclays Remains a Buy on Novonesis (0Q4U)
Jefferies
kr450
Buy
18.08%
Upside
Reiterated
04/23/26
Jefferies Remains a Buy on Novonesis (0Q4U)
J.P. Morgan Analyst forecast on GB:0Q4U
J.P. Morgan
J.P. Morgan
kr540kr500
Buy
31.20%
Upside
Reiterated
04/09/26
Novonesis price target lowered to DKK 500 from DKK 540 at JPMorganNovonesis price target lowered to DKK 500 from DKK 540 at JPMorgan
Rothschild & Co Redburn Analyst forecast on GB:0Q4U
Rothschild & Co Redburn
Rothschild & Co Redburn
kr445
Buy
16.77%
Upside
Upgraded
03/27/26
Novonesis upgraded to Buy from Neutral at Rothschild & Co RedburnNovonesis upgraded to Buy from Neutral at Rothschild & Co Redburn
Berenberg Bank Analyst forecast on GB:0Q4U
Berenberg Bank
Berenberg Bank
kr478kr410
Buy
7.58%
Upside
Reiterated
03/11/26
Novonesis price target lowered to DKK 410 from DKK 478 at BerenbergNovonesis price target lowered to DKK 410 from DKK 478 at Berenberg
Morgan Stanley Analyst forecast on GB:0Q4U
Morgan Stanley
Morgan Stanley
kr569kr560
Buy
46.94%
Upside
Reiterated
11/26/25
New Buy Rating for Novonesis (0Q4U), the Technology Giant
Goldman Sachs Analyst forecast on GB:0Q4U
Goldman Sachs
Goldman Sachs
kr550
Buy
44.32%
Upside
Reiterated
11/11/25
New Buy Rating for Novonesis (0Q4U), the Technology Giant
UBS
kr470kr445
Buy
16.77%
Upside
Reiterated
09/30/25
Novonesis (0Q4U): New Buy Recommendation for This Technology Giant
Deutsche Bank
kr490kr480
Buy
25.95%
Upside
Reiterated
09/24/25
Novonesis (0Q4U): New Buy Recommendation for This Technology Giant
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novonesis

3 Months
Success Rate
11/17 ratings generated profit
65%
Average Return
+0.34%
Copying Charles Eden's trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +0.34% per trade.
1 Year
Success Rate
10/17 ratings generated profit
59%
Average Return
+7.16%
Copying Charles Eden's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +7.16% per trade.
2 Years
Success Rate
11/17 ratings generated profit
65%
Average Return
+8.69%
Copying Charles Eden's trades and holding each position for 2 Years would result in 64.71% of your transactions generating a profit, with an average return of +8.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0Q4U Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
4
1
6
8
11
Hold
1
1
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
2
8
10
13
In the current month, 0Q4U has received 11 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 0Q4U average Analyst price target in the past 3 months is 453.57.
Each month's total comprises the sum of three months' worth of ratings.

0Q4U Financial Forecast

0Q4U Earnings Forecast

Next quarter’s earnings estimate for 0Q4U is kr4.92 with a range of kr3.91 to kr6.87. The previous quarter’s EPS was kr4.29. 0Q4U beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year 0Q4U has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0Q4U is kr4.92 with a range of kr3.91 to kr6.87. The previous quarter’s EPS was kr4.29. 0Q4U beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year 0Q4U has Performed in-line its overall industry.

0Q4U Sales Forecast

Next quarter’s sales forecast for 0Q4U is kr8.26B with a range of kr8.18B to kr8.35B. The previous quarter’s sales results were kr8.36B. 0Q4U beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year 0Q4U has Performed in-line its overall industry.
Next quarter’s sales forecast for 0Q4U is kr8.26B with a range of kr8.18B to kr8.35B. The previous quarter’s sales results were kr8.36B. 0Q4U beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year 0Q4U has Performed in-line its overall industry.

0Q4U Stock Forecast FAQ

What is GB:0Q4U’s average 12-month price target, according to analysts?
Based on analyst ratings, Novonesis’s 12-month average price target is 453.57.
    What is GB:0Q4U’s upside potential, based on the analysts’ average price target?
    Novonesis has 19.02% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Novonesis a Buy, Sell or Hold?
          Novonesis has a consensus rating of Strong Buy, which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Novonesis’s share price target?
            The average share price target for Novonesis is 453.57. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr500.00 ,and the lowest forecast is kr410.00. The average share price target represents 19.02% Increase from the current price of kr381.1.
              What do analysts say about Novonesis?
              Novonesis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Novonesis?
                To buy shares of GB:0Q4U, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.